Questions discussed in this category
Specifically referring to SLE and not a true 'Rhupus' overlap patient. How do you weigh the safety or risk of the use of these agents in SLE patients?...
E.g., inflammatory polyarthritis or inflammatory myopathy with onset within 2 weeks of documented COVID infection
25686140301538810502807516352131291049796139022
Papers discussed in this category
Ann. Rheum. Dis., 2019 Sep 20
Lancet Rheumatol, 2021 Apr 06
N Engl J Med, 2020 Nov 20
Arthritis Rheum,
Autoimmun Rev, 2012 Nov 30
Chest, 2021 Feb